Class I/B antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparations.
Szél T, Koncz I, Jost N, Baczkó I, Husti Z, Virág L, Bussek A, Wettwer E, Ravens U, Papp JG, et al. Eur J Pharmacol. 2011 Jul 15; 662(1-3):31-9. Epub 2011 May 1.